Market Overview

Synageva BioPharma Falls 3%

Shares of Synageva BioPharma (NASDAQ: GEVA) have lost 3.34% on Monday after a strong showing last week. Volume has been slightly above normal with around 81,000 GEVA shares trading hands compared to a 3-month daily average of 73,000.

The stock has risen around 157% over the last 6 months. Over the last 3 months, GEVA has added a little more than 6%. At current prices, the company has a market cap of $844 million.

Posted-In: Intraday Update Movers

 

Related Articles (GEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters